CLINAM, May 17-20, 2020

Laboratory co-Director and Head of NCL’s Immunology Section, Dr. Marina Dobrovolskaia, will be co-chairing a session with Dr. Janos Szebeni, Semmelweis University, on “Immune Modulation by Nanomedicines: New Therapeutic Approaches, Adverse Phenomena and Safety Testing”. Additionally, Marina will be speaking in the session on “Emerging Biomarkers of Nanoparticle Immunotoxicity: an Outlook in Future.”

Access the preliminary CLINAM 2020 agenda here: https://www.clinam.org/images/clinam2020/WEB-CLINAM%20PRELPROG1.pdf